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a  b  s  t  r  a  c  t
Type  1 diabetes  mellitus  (T1DM)  is an autoimmune  destruction  of  insulin  producing  pan-
creatic  beta-cells  due  to a  genetic  predisposition  and  can  be  triggered  by environmental
factors.  We  have  previously  shown  that  bisphenol  A (BPA)  accelerates  the  spontaneous
development  of diabetes  in non-obese  diabetic  (NOD)  mice.  Here,  we hypothesized  that
oral  exposure  to a mixture  of the  endocrine  disruptors  BPA  and  phthalates,  relevant  for
human  exposure,  would  accelerate  diabetes  development  compared  to BPA  alone.  NOD
mice  were  exposed  to  BPA  (1 mg/l),  a  mixture  of phthalates  (DEHP  1 mg/l,  DBP  0.2  mg/l,
BBP  10  mg/l  and  DiBP  20 mg/l)  or a  combination  of  BPA  and  the  phthalate  mixture  through
drinking  water  from  conception  and  throughout  life.  Previous  observations  that  BPA  expo-
sure increased  the  prevalence  of  diabetes  and  insulitis  and  decreased  the  number  of tissue
resident  macrophages  in pancreas  were  conﬁrmed,  and  extended  by  demonstrating  that
BPA exposure  also  impaired  the  phagocytic  activity  of peritoneal  macrophages.  None  of
these  effects  were  observed  after phthalate  exposure  alone.  The  phthalate  exposure  in  com-
bination with  BPA  seemed  to dampen  the  BPA  effects  on macrophage  number  and  function
as  well  as  diabetes  development,  but not  insulitis  development.  Exposure  to BPA  alone  or
in combination  with  phthalates  decreased  cytokine  release  (TNF,  IL-6,  IL-10,  IFN,  IL-4)
from in  vitro  stimulated  splenocytes  and  lymph  node  cells,  indicating  systemic  changes  in
immune  function.  In  conclusion,  exposure  to BPA,  but not  to phthalates  or mixed  exposure
to  BPA  and  phthalates,  accelerated  diabetes  development  in NOD  mice,  apparently  in  part
via systemic  immune  alterations  including  decreased  macrophage  function.
© 2015  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
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1. Introduction
Diabetes mellitus type 1 (T1DM) is an autoimmune
disease where pancreatic beta-cells are destroyed by
autoreactive immune cells, resulting in insulin deﬁciency.
During the last decades, the incidence has increased in
many European countries [1]. T1DM develops on a pre-
disposing genetic background, and can be triggered by
is is an open access article under the CC BY-NC-ND license
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several environmental factors. Examples of triggering envi-
ronmental factors are intestinal viruses and vitamin D
deﬁciency or possible disturbances in the development of
the foetal immune system [2]. Some evidence of associ-
ations between T1DM and environmental pollutants like
PCBs, ozone and sulphate, has been reported in epidemio-
logical studies [35,3,4].
Noteworthy, an increasing human exposure burden of
endocrine disruptors like bisphenol A (BPA) and phtha-
lates has been reported [5] in the same time frame as the
increased T1DM prevalence [6].
BPA is used in the production of polycarbonate plastic
bottles and food containers as well as epoxy resins in the
lining of metal cans. BPA leaking into food and beverages is
the major human BPA exposure. BPA has been detected in
over 90% of all analyzed human urine samples, indicating
a widespread human exposure to BPA [7]. Ingested BPA
is rapidly conjugated in the liver and is excreted in the
urine within 24 h. BPA is only biologically active in its
unconjugated form.
Phthalates are used as plasticizers and found in a vari-
ety of consumer products. Phthalates are also rapidly
metabolized and secreted via urine. For many phthalates,
including diethylhexyl phthalate (DEHP), dibutyl phthalate
(DBP), butylbenzyl phthalate (BBP) and di-i-butyl phtha-
late (DiBP), ingestion seems to be the main exposure
route in humans [8]. As for BPA, phthalate metabolites are
widely detected in urine, conﬁrming a widespread expo-
sure [9,10]. However, both the phthalate parent form and
the metabolites may  be biologically active [11].
Exposure to endocrine disruptors like phthalates and
BPA has not been studied in relation to development of
T1DM in epidemiological studies, most likely because such
studies are hampered by the low incidence in humans
making prospective studies particularly difﬁcult. However,
T1DM is an immunological disease, and in epidemiological
studies exposure to both phthalates and BPA has been asso-
ciated with negative effects on or related to the immune
system, such as asthma, allergies, altered levels of thyroid
hormones, and inﬂammatory diseases like diabetes type 2
and cardiovascular disease [11–23].
BPA exposure has also been reported to modulate the
immune system in animal studies, by promoting asthma
and allergy development in experimental mouse models
[24], as well as having a modulatory effect on macrophage
activity [25–27,56]. Similarly, phthalates increased
inﬂammation in a murine peritonitis model, inhibited
alveolar macrophage killing of bacteria, and reduced
phagocytic activity, suggesting that phthalates may  impair
macrophage functionality [28,29,32]. In vitro studies also
report that phthalates can induce differentiation [30] and
increased apoptosis in RAW264.7 macrophages [31,32].
Some experimental studies have assessed the impact
of BPA on diabetes development and cellular endpoints
relevant for diabetes, but type 2 diabetes has received
most attention. Impaired mitochondrial function and
altered morphology of the insulin producing beta-cells
has been reported in BPA exposed rat primary pancreatic
islets in vitro [33]. We  have previously reported that both
long term BPA exposure starting at 4 weeks of age contin-
uing through-out life and exposure during gestation andorts 2 (2015) 99–110
lactation only, accelerated the spontaneous development
of T1DM in NOD mice [34–36]. However, a possible impact
of phthalates on T1DM development has not been studied
previously.
In the present study, we examine the effects of BPA
(1 mg/l), a mixture of phthalates (DEHP 1 mg/l, DBP
0.2 mg/l, BBP 10 mg/l and DiBP 20 mg/l) or a combination
of BPA and the phthalate mixture on T1DM development
in the NOD mice, after exposure through drinking water
from conception and throughout life of the offspring. We
hypothesized that oral exposure to a combination of BPA
and phthalates, relevant for human mixed exposures, could
give a more rapid acceleration of the diabetes development
than BPA alone. In addition, we further explore the role
of macrophages and systemic effects induced by environ-
mental chemicals in the diabetes development in the NOD
mouse model.
2. Materials and methods
2.1. Mice and exposure conditions
120 female (randomized into four groups) and 60 male
non diabetic NOD/ShiLtJ mice from Jackson Laboratory
(Maine, USA) were used for breeding at 8 and 10 weeks
of age, respectively. The exposure to BPA and/or phtha-
lates via drinking water started at the time of mating of
the mice and continued throughout the life time of the
female offspring. The 4 exposure groups included: (1) neg-
ative control (water only), (2) phthalates: DEHP 1 mg/l, DBP
0.2 mg/l, BBP 10 mg/l and DiBP 20 mg/l, (3) BPA 1 mg/l, and
(4) BPA 1 mg/l + DEHP 1 mg/l, DBP 0.2 mg/l, BBP 10 mg/l and
DiBP 20 mg/l. The exposure level of each chemical was cho-
sen at a dose corresponding to 3 × tolerable daily intake
(TDI) for the respective chemical, since BPA at this exposure
level has previously been shown to affect T1DM develop-
ment in NOD mice [36].
Only female offspring were selected at the time of
weaning, since insulitis and diabetes development is most
prevalent in female mice [37]. The endocrine disruptors
(EDs) were dissolved in deionized autoclaved water heated
to 60 ◦C. Controls received similar water without EDs.
BPA-free water bottles, made of 100% polyethylene tereph-
thalate (PET) that does not require the use of phthalates or
other softening additives (Innovive, San Diego, USA) were
used and the water was  changed once every week. Also
cages were BPA-free and with minimal leakage of phtha-
lates (100% PET polyethylene terephthalate plastic). The
diet contained minimal levels of phytoestrogens (2919X,
Harlan Laboratories, Indianapolis, USA) and the mice had
free access to feed and water. The mice were exposed
to a 12-h light/12-h dark cycle and 35–75% humidity. To
keep the dams as the statistical unit for all data, female
siblings from each dam (approximately 3–4 females/dam)
were separated into different cages, and divided into 4
sub-groups; (i) 25 female offspring were used to monitor
diabetes development by weekly measurements of blood
glucose from 6 to 35 weeks of age, and blood samples were
collected at 6 and 10 weeks of age, (ii and iii) two sepa-
rate subgroups, each containing 8 offspring, were used for
histological examination of pancreas, ex vivo assessment
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f phagocytic function of isolated peritoneal macrophages
nd isolation of splenocytes and pancreatic lymph node
ells at 7 and 11 weeks of age, respectively, and (iv) a sub-
roup of 4 offspring was used for isolation of pancreatic
slets at 8 weeks of age, for ex vivo assessment of cytokine
nduced apoptosis induction. All experiments were per-
ormed in conformity with the laws and regulations for
xperiments with live animals and were approved by the
ocal representative of the Norwegian Animal Research
uthority.
.2. Blood glucose measurements
In the diabetes development sub-group, all mice were
onitored for blood glucose levels every week from 6 to
5 weeks of age, whereas for the two histology sub-groups,
lood glucose levels were only determined once before
uthanizing at the age of 7 or 11 weeks of age. Blood
lucose levels were determined in blood samples from the
emoral vein using Accu-Check (Roche Diagnostics, GmbH
annheim, Germany). Mice were considered diabetic
fter two consecutive measurements within 24 h with
lucose levels above 13.9 mmol/l and were immediately
uthanized.
.3. Serum insulin and testosterone measurements
Since testosterone has been shown to protect against
iabetes development in NOD mice [38] the serum testos-
erone levels were analyzed in blood samples from 10
eeks old NOD mice. Further, elevated insulin secre-
ion may  also be protective against diabetes in the NOD
ouse and BPA has been shown to induce insulin secre-
ion in beta cells [39,45]. Therefore, the non-fasting serum
nsulin levels were also determined at week 10. Serum
nsulin and testosterone concentrations were determined
ith ELISA-kits from Mercodia (Uppsala, Sweden) and
RG Instruments GmbH (Marburg, Germany), respectively,
ccording to the manufacturer’s recommendations.
.4. Histological evaluation
For histological evaluation, pancreata were collected
rom 8 mice (at 7 and 11 weeks of age), ﬁxed in for-
alin, embedded in parafﬁn and processed as described
reviously before haematoxylin and eosin staining [34,35].
or each mouse 6 sections at different depth of the pan-
reas were examined and all islets present in the sections
10–15 islets/section) were graded for insulitis accord-
ng to the area of an islet inﬁltrated by lymphocytes.
% inﬁltration = grade 0, periinsulitis and up to 10% inﬁl-
ration = grade 1, 10–49% inﬁltration = grade 2, 50–74%
nﬁltration = grade 3 and 75–100% inﬁltration = grade 4,
s previously illustrated [36]. For each section, an over-
ll grade was assigned which corresponded to the highest
rade detected in at least 3 islets. Then, the ﬁnal grade for pancreas/mouse was set to the highest grade determined
or the 6 analyzed sections. The mean insulitis grade for
ach exposure group corresponds to the mean of the ﬁnal
ancreas grade for each mouse.orts 2 (2015) 99–110 101
Sections of the formalin ﬁxed pancreas were also
stained over-night with antibodies towards Foxp3 (reg-
ulatory T-cells, eBioscience, San Diego, USA, 1:50), F4/80
(tissue resident macrophages, AbD Serotec, Oxford, UK,
1:50) and CD68 (invasive macrophages, AbD Serotec,
1:300), and active caspase-3 (apoptotic cells, Cell Sig-
nalling Technology, Beverly, MA,  USA, 1:400), as previously
described [36]. For each antibody staining and insulitis
grade, the number of positive cells per islet was counted
in two pancreatic sections per mouse. The counts per islet
were compared between the exposure groups within each
insulitis grade with a particular focus on grade 0 islets to
investigate the effects of exposure on initial events in dia-
betes development.
2.5. Phagocytic function of peritoneal macrophages
To investigate if the exposures affected the macrophage
functionality, the phagocytic activity of peritoneal
macrophages was  investigated by ﬂow cytometry. Peri-
toneal macrophages were isolated from mice at 7 and
11 weeks of age (n = 8) by peritoneal lavage. The cell
suspension was  centrifuged at 250 × g for 10 min  and
erythrocytes were removed by dissolving the cell pellet
in 0.2% NaCl on ice for 4 min. The cell concentration was
determined and cells were seeded at 2 × 106 cells/ml in
48 wells plates with RPMI cell culture medium. After 1 h
of culture 85–95% of the attached cells are assumed to
be macrophages [40]. Then the medium with unattached
cells was discarded, replaced with fresh medium, and the
cells were incubated over night. To assess the phagocytic
function, FITC-labelled Zymosan particles were added at
a ratio 20 particles per cell (In vitrogen Life Technologies,
Carlsbad, CA, United States) incubated for 30 min  at 37 ◦C,
washed twice in PBS and incubated with Accutase (In
vitrogen Life Technologies) for at least 15 min  to remove
particles from cell surfaces and to detach cells. The cells
were washed twice with PBS, ﬁxed in 0.2% paraformalde-
hyde in cell culture medium and analyzed for phagocytosis
(FITC intensity per cell) by ﬂow cytometry (LSR II, BD
Bioscience, Franklin Lakes, NJ, USA).
2.6. Insulin secretion and NO production in isolated
pancreatic islets
Pancreatic islets were isolated from 8 weeks old NOD
mice (n = 5) as previously described [41] using injection
of collagenase in the porta vein of euthanized animals
before excision of the pancreas. Further dispersion of whole
islets was  performed in 37 ◦C collagenase for 17 min, after
which islets were washed and thereafter hand-picked with
pipette from a petri dish using a microscope. Glucose-
induced insulin secretion was  determined for 10 islets of
equal size per mice as described previously [42]. Brieﬂy,
islets were incubated in glucose free medium in 48 wells
plates for 30 min  before a 60 min  stimulation with either 6
or 16 mM glucose. Supernatants were harvested for insulin
determination according to manufacturer’s recommenda-
tion (ELISA, Mercodia) and islets were frozen for analysis
of protein content.
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Fig. 1. (A) Spontaneous cumulative diabetes incidence i.e. a glucose level above threshold for diabetes in these mice (13.9 mmol/l), shown as percentage
of  diabetic female offspring of NOD mice exposed to BPA and phthalate in the drinking water from before birth and throughout life (n = 25). The blue line
represents animals receiving 1 mg/l BPA exposure, the turquoise line the phthalate exposed mice (DEHP 1 mg/l, DBP 0.2 mg/l, BBP 10 mg/l and DiBP 20 mg/l
corresponding to 3 times tolerable daily intake for each chemical), the black line the combination of BPA and phthalates and the red line resembles the
control  group. (B) Histological evaluation of insulitis grade in pancreatic islets from 7 and 11 weeks old female NOD offspring after continuous BPA and
phthalate exposure. Formalin ﬁxed pancreas were sectioned and stained with haematoxylin–eosin and evaluated for severity of lymphocyte inﬁltration
using  light microscopy (n = 8). Grade 0 = no inﬁltration, grade 1 = periinsulitis <10% inﬁltration, grade 2 = 10–49% inﬁltration, grade 3 = 50–74% inﬁltration,
set to th
 percentand  grade 4 = 75–100% inﬁltration. The insulitis grade per pancreas was  
sections from different depths (5–15 islets per section), and presented as
NO production was measured using the Griess assay
(Sigma–Aldrich) according to manufacturer’s instruc-
tions.
2.7. Isolation of beta-cells and islet macrophages,
analysis of cytokine induced apoptosisTo investigate the cellular sensitivity to cytokine-
induced apoptosis [43], 60 isolated pancreatic islets from 4
offspring per exposure group were incubated for 48 h and
stimulated with 50 U/ml rm-IL-1, 1000 U/ml rm-INFe highest grade observed in 3 or more islets after grading all islets in 3
age of mice within each insulitis grade.
and 1000 U/ml rm-TNF. The islets were then moved to
1 ml  calcium free HEPES-based beta-cell isolation solution
and incubated for 12 min  at 37 ◦C, before 2 ml  RPMI
medium (5% FCS) was added and the islets were dispersed
by harsh pipetting. The cell suspension were washed and
resuspended in binding buffer (BD Biosciences, Franklin
Lakes, NJ, USA) stained for PE-annexin V (apoptotic cells,
BD Biosciences), PI 7-AAD (necrotic cells, BD Biosciences)
and APC-F4/80 (macrophages, eBioscience). Cells were
ﬁxed and permeabilized for intracellular paciﬁc blue-
insulin (beta cells, Cell Signalling Technology, Beverly, MA,
J. Bodin et al. / Toxicology Reports 2 (2015) 99–110 103
Fig. 2. Immunohistochemical staining of sections of formalin ﬁxed pancreas in female NOD offspring after continuous BPA and phthalate exposure. (A)
Mean number of tissue resident macrophages (F4/80 positive cells) in pancreatic islets of grade 0 from 7 and 11 weeks old mice. (B) Representative pictures
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rade  0, from 7 weeks old control and BPA exposed mice. All islets from
ifferences from the control group, p < 0.05.
SA) staining. Flow cytometry was applied to determine
he percentage of apoptotic and necrotic beta cells and
poptotic macrophages originating from the pancreatic
slets challenged with cytokines in vitro.
.8. Cytokine release in ex vivo stimulated splenocytes
nd pancreatic lymphocytesSplenocytes and pancreatic lymph node cells were iso-
ated at 7 and 11 weeks of age (n = 8) as previously described
34,35]. Subsequently, cytokine secretion upon ex vivo
timulation for 48 h with LPS or ConA was determined the brown colour of F4/80 positive cells) in pancreatic islets with insulitis
ons per pancreas were analyzed (group mean ± SEM, n = 8). *Signiﬁcant
for all exposure groups in splenocyte cell cultures and
with LPS in pancreatic lymph node cell and islet cul-
tures, to examine possible effects on systemic immune
functions, performed as previously described [34,35,44].
Stimulation with LPS activates B-cells and macrophages
(10 g/ml, Sigma–Aldrich, GmbH Steinheim, Germany),
while ConA stimulation for 48 h activates T-cells (50 g/ml,
Sigma–Aldrich). The cytokine levels (INF, TNF, IL-1, IL-
2, IL-4, IL-6, IL-10, IL-13 and IL-17) in the supernatants were
determined by cytometric bead based array (FlexSet, BD
Bioscience) analyzed on a LSRII ﬂow cytometer (BD Bio-
science).
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Fig. 3. Immunohistochemical results from sections of formalin ﬁxed
pancreas in female NOD offspring after continuous BPA and phthalate
exposure. Mean number of apoptotic cells (active caspasae-3 positive104 J. Bodin et al. / Toxico
2.9. Statistical analysis
Data are presented as group means ± standard errors of
the mean (SEM). Diabetes incidence data were analyzed
by Cox regression analysis, while all other data sets were
analyzed by one way analysis of variance (ANOVA). The
Holm–Sidiak post hoc test was performed to evaluate sig-
niﬁcant differences between the groups. For all analyses,
p-values <0.05 were considered statistically signiﬁcant.
3. Results
3.1. Diabetes development
In the evaluation of diabetes development, mice with
sustained elevated blood glucose levels, at 13.9 mmol/l or
above, at two measurements within 24 h were considered
diabetic. The spontaneous diabetes development started
from 12 to 14 weeks of age in NOD mice for all expo-
sure groups (Fig. 1A). The diabetes incidence in the BPA
treated group seemed to be increased from 25 weeks of age
compared to the control group. However, cox regression
analysis did not conﬁrm statistical differences between the
exposure groups. Phthalate exposure or the combination of
BPA and phthalates did not affect diabetes development to
the same extent as BPA alone. In the histological evalua-
tion of insulitis, there were no signiﬁcant differences in the
mean insulitis grade between the exposure groups at 7 or
11 weeks of age (Fig. 1B). However, the percentage of mice
with a ﬁnal insulitis grade of 4 at 11 weeks of age were 62.5%
and 75% in the BPA and the combined BPA and phthalate
exposure groups, respectively, compared to 37.5% in the
control group (Fig. 1B), suggesting an accelerated insulitis
development in these two groups. The number of offspring
(in average about 8 per dam), sex distribution (mean 50%
females), body weight (mean 11, 23 and 29 g at age 3, 11 and
20 weeks respectively) or water intake at 10 and 20 weeks
of age (typically 3 and 3.5 ml  per animal per day, respec-
tively) were not affected by any of the exposures. Likewise,
the non-fasting serum levels of insulin or testosterone did
not differ between the exposure groups (data not shown).
3.2. Cellular inﬁltration in the pancreatic islets
Prior to insulitis (i.e. in islets with insulitis grade 0), the
number of F4/80+ tissue resident macrophages was signif-
icantly reduced in the BPA exposed group at 7 weeks of age
compared to control (Fig. 2). The same trend was observed
at 11 weeks of age, although not statistically signiﬁcant. In
contrast, exposure to phthalates or the combination of BPA
and phthalates, did not reduce the number of tissue resi-
dent macrophages signiﬁcantly compared to control prior
to insulitis at 7 or at 11 weeks of age. That is, all of the
exposure groups except BPA alone having about 5 tissue
resident macrophages per section of islet at grade 0 at 7
weeks of age (Fig. 2A). However, the number of apoptotic
cells, evaluated by the number of active caspase-3 positive
cells, was increased both in the BPA and the combined BPA
and phthalates exposure groups (Fig. 3) compared to the
control at 11 weeks of age. A similar trend was  observed
after 7 weeks of age after BPA exposure, with increasedcells) per pancreatic islet of grade 0 at 7 and 11 weeks of age. All islets
from 2 sections per pancreas were analyzed (group mean ± SEM, n = 8).
*Signiﬁcant differences from the control group, p < 0.05.
apoptotic cells in pancreatic islets at grade 0, although not
signiﬁcantly different from control (Fig. 3). Phthalate expo-
sure alone did not affect the number of apoptotic cells in
pancreatic islets at any time point, nor was the number of
regulatory T-cells and CD68+ macrophages affected by any
of the environmental chemical exposures (data not shown).
The apoptotic cells observed in the islets after BPA expo-
sure were identiﬁed in an earlier study to be alpha cells,
beta cells and tissue resident macrophages [34,35].
3.3. Phagocytic function of peritoneal macrophages
BPA exposure alone decreased the relative number
of phagocytic macrophages with about 30% compared
to control levels at 7 weeks of age (Fig. 4), suggesting
impaired macrophage function. In contrast, exposure to
phthalates alone or in combination with BPA did not affect
the phagocytic function in peritoneal macrophages signif-
icantly (Fig. 4). There was  a similar trend, however not
statistically signiﬁcant at 11 weeks of age (Fig. 4).
3.4. Insulin secretion and NO production in pancreatic
islets
There was no difference between the exposure groups
in the glucose induced insulin secretion or in the NO pro-
duction in isolated pancreatic islets (data not shown).
3.5. Apoptosis sensitivity in isolated beta cells and
macrophagesThe percentage of apoptotic beta cells after in vitro
cytokine stimulation was  lower in mice from the phthalate
exposure group at 8 weeks of age compared to the control
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hthalate exposure, % phagocytic macrophages determined by ﬂow cytom
 < 0.05. Panel B shows FITC-conjugated Zymosan particles (green) and m
roup, suggesting a decreased sensitivity to cytokine-
nduced apoptosis in these cells (Fig. 5A). A similar but
on-signiﬁcant trend was observed for the combined BPA
nd phthalate exposures. For macrophages, the percentage
f apoptotic cells was increased in the BPA exposure group
ompared to the control, suggesting increased sensitivity
o cytokine-induced apoptosis in macrophages (Fig. 5B).
.6. Cytokine release from splenocytes, pancreatic lymph
ode cells and pancreatic islets
Possible systemic immunomodulating effects of BPA
nd phthalate exposure in NOD mice were examined by 7 and 11 weeks of age in female NOD offspring after continuous BPA and
roup mean ± SEM, n = 8). *Signiﬁcant differences from the control group,
ge nuclei (blue) in a cytospin sample after phagocytosis analysis.
ex vivo stimulation of splenocytes and pancreatic lymph
node cells with LPS (activating B-cells and macrophages)
and ConA (activating T-cells). ConA stimulation of spleno-
cytes ex vivo resulted in increased release of IL-6 in the
phthalate exposure group, and reduced release of IL-10, IL-
4 and TNF in both the BPA and the combined BPA and
phthalate exposure groups compared to control (Fig. 6A).
Exposure to BPA alone or in combination with phthalates
generally decreased the LPS-induced in vitro secretion of
TNF, IL-6, IL-10 and IFN in splenocytes, with the largest
effects for the combined exposure group (Fig. 6B). Levels of
IL-4 were below the detection level after LPS stimulation
in splenocytes.
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Fig. 5. Sensitivity of beta-cells and macrophages from pancreatic islets to ex vivo cytokine-induced apoptosis, after continuous BPA and phthalate exposure,
 of total 
 water 
 of age (isolated from 8 week old offspring. Apoptotic pancreatic beta cells (A) in %
8  weeks old female NOD mice exposed to BPA and phthalates in drinking
numbers in pancreatic islets isolated from exposed NOD mice at 8 weeks
Ex vivo LPS stimulated pancreatic lymph node cells
also showed a non-signiﬁcant trend for decreased lev-
els of TNF and IL-6 secretion in the BPA and combined
BPA and phthalate exposure group (Fig. 6A), whereas IL-
4 and IFN levels were below the detection limit. Overall,
exposure to BPA alone or in combination with phthalates
induced systemic effects in the NOD mice in terms of
altered functionality of splenocytes and pancreatic lymph
node cells. There were no signiﬁcant differences in LPS-
induced cytokine secretion from isolated pancreatic islets,
except for a non-signiﬁcant trend of decreased LPS-induced
IL-10 secretion after combined BPA and phthalate exposure
(Fig. 6D).
4. Discussion
This study conﬁrms our previous ﬁndings that expo-
sure to BPA through the drinking water increases diabetes
development in NOD mice [34–36]. In contrast, phthalate
exposure or mixed exposure to BPA and phthalates, did not
affect diabetes development. The combined BPA and phtha-
late exposure did, however, induce systemic alterations in
the immune system, seen as altered cytokine responses in
splenocytes and pancreatic lymphocytes. Phthalate expo-
sure alone only leads to increased IL-6 secretion after ex
vivo T-cell stimulation of splenocytes and seemed to have a
protective effect against ex vivo-induced apoptosis in beta-
cells.
BPA exposure alone increased the number of diabetic
mice at 25 weeks of age, whereas phthalate or the com-
bined BPA and phthalate exposure did not affect the
diabetes incidence. We  even observed an apparent coun-
teracting effect of phthalates on the BPA-induced increase
in diabetes, i.e. a lack of effect of the mixture of BPA and
phthalates on the diabetes incidence. This could be duebeta cells after 48 h cytokine induced apoptosis in beta cells isolated from
(n = 4). Panel B shows % apoptotic macrophages out of total macrophage
n = 4).*Signiﬁcant differences from the control group, p < 0.05.
to a non-monotonic dose response effect, since BPA and
each phthalate was  given at a 3 × tolerable daily intake
level (TDI), and higher doses of estrogenic compounds have
been reported to increase the insulin release in beta-cells
and delay the spontaneous diabetes development in NOD
mice [45–48]. In line with this, we  previously showed
that a higher exposure of BPA (100 mg/l in drinking water
reduced the development of diabetes in NOD mice [36]).
Another explanation of the apparent opposing effect
of phthalates could be linked to the observed increase in
IL-6 secretion from immune cells in the phthalate expo-
sure group. Since it has been shown that IL-6 enhances
glucose induced insulin secretion in pancreatic beta-cells
[49,50], this could contribute to a delay of the T1DM
development by increasing serum insulin levels. In mice
from the phthalate-exposed groups (with or without BPA)
the sensitivity to cytokine induced apoptosis was reduced
in isolated beta cells. Interestingly, IL-6 has also been
reported to protect beta-cells from cytokine-induced apo-
ptosis [49–51]. Accordingly, the reduced sensitivity with
regard to beta-cell apoptosis, possibly through elevated IL-
6 levels, may  be another explanation of how the phthalates
can counteract the BPA-induced diabetes development in
NOD mice.
In our previous studies, the largest differences between
the exposure groups in the insulitis development were
observed at 11 weeks of age. However, in the present study,
the tendency towards a higher insulitis grade per mouse
and exposure group for BPA and combined BPA and phtha-
late exposure was not signiﬁcantly different compared
to the control group. In retrospect, however, 11 weeks of
age might be before the time-point exhibiting the largest
differences in insulitis development, since the mice in the
present study developed diabetes later in life compared
to our previous studies using the same strain and housing
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Fig. 6. TNF, IL-6, IL-10, IFN and IL-4 cytokine release in cells isolated from 11 weeks old NOD offspring continuously exposed to BPA and phthalates
(group mean ± SEM, n = 8). ConA-induced (A) and LPS-induced (B) cytokine release from splenocytes. (C) LPS-induced cytokine release from pancreatic
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praining lymph node cells. (D) LPS-induced cytokine release from pancrea
he  cytokine levels in general were below detection limits. *Signiﬁcant di
onditions [34–36]. Stress and infections are known to
elay diabetes development in NOD mice [52–54]. How-
ver, a thorough pathological examination of 5 NOD mice
n the population gave no indications of infection.
Fewer tissue resident macrophages and/or impaired
acrophage function can potentially result in a decreased
learance of apoptotic cells and a more severe insulitis
rade [55]. We  observed an increased number of apoptotic
ells in pancreatic islets prior to insulitis both for BPA and
ombined BPA and phthalates exposure, but not phthalate
xposure alone, suggesting a possible direct toxic effect
r an effect on the macrophage clearance function by
PA exposure. With regard to direct toxic effects, the
PA-induced increase in pancreatic apoptotic cells seemed
o be evident in all populations analyzed, including beta
ells, alpha cells and tissue speciﬁc macrophages [34,35].
owever, several observations in the present study sup-
ort the notion that BPA affects macrophage numbers and
unctionality. Firstly, the analysis of phagocytosis revealed
hat BPA exposure decreased the phagocytic function in
eritoneal macrophages in NOD mice. Secondly, a reduceds. All cytokines were measured for all cell types, but are not shown when
s from the control group, p < 0.05.
LPS-induced cytokine release from splenocytes, lymph
node cells and possibly also pancreatic islets, sug-
gested impaired release of inﬂammatory cytokines from
macrophages in general after exposure to BPA alone or
in combination with phthalates. Both these observations
are in line with a previously reported lower peritoneal
macrophage function due to BPA exposure, seen as
decreased NO and TNF production in BPA exposed
murine peritoneal macrophages [56]. Lastly, BPA exposure
increased the sensitivity of pancreatic macrophages to
cytokine induced apoptosis and reduced the number of
tissue resident macrophages in pancreatic islets. Thus, one
may  hypothesize that this increased apoptosis sensitivity
could contribute to the reduced pancreatic macrophage
numbers prior to insulitis. Why  some of these endpoint
effects appeared to be opposed by phthalates (number of
tissue-resident macrophages, macrophage phagocytosis)
while others were not (increased apoptosis sensitivity,
LPS-induced cytokine secretion) cannot be determined
from the present study. It is possible, however, that the
observed phthalate induced effects (increased IL-6 from
logy Rep
[
[
[
[
[
Hasselgren, L. Hagerhed-Engman, The association between asthma
and allergic symptoms in children and phthalates in house dust: a
nested case–control study, Environ. Health Perspect. 112 (14) (2004)108 J. Bodin et al. / Toxico
lymphocytes), or other phthalate induced effects on the
immune system that were not assessed presently, could
affect the above endpoints differently and thereby explain
why only some BPA-induced effects were counteracted by
phthalates.
Presently, the combined BPA and phthalate exposure
decreased LPS-induced IL-6, IL-10 and IFN secretion
and ConA-induced IL-10 and TNF secretion in spleno-
cytes in vitro, while BPA exposure alone decreased
the LPS-induced IL-10 and TNF secretion. The anti-
inﬂammatory cytokine IL-10 is necessary for maintenance
of Foxp3 expression in regulatory T-cells [57], which are
involved in the suppression of cytotoxic T-cell prolifera-
tion. Further, IL-10 acts as a potent immunosuppressant
in itself, by reducing pro-inﬂammatory cytokine release
in activated monocytes, polymorphonuclear leukocytes
and eosinophils [58]. Thus, it can be speculated that the
increased insulitis and diabetes development induced by
BPA exposure in part could be related to reduced IL-10 pro-
duction with subsequent reduced clearance of apoptotic
cells and an increase in the peripheral pool of cytotoxic
T-cells in the pancreas. This is in line with a study by
Khanna and co-authors [59], reporting increased inﬂam-
mation and reduced clearance of apoptotic cells in wounds
of diabetic mice, possibly caused by a reduced level of the
anti-inﬂammatory cytokine IL-10 secreted from wound-
related macrophages.
Moreover, since lower levels of TNF secreted by
splenocytes and lymphocytes were observed after a mixed
exposure to BPA and phthalates, this could reﬂect a reduced
inﬂammation process and thereby potentially contribute
to reduce the BPA-induced acceleration in diabetes devel-
opment in NOD mice. The local insulitis in the pancreas
was not decreased after the combined exposure, suggesting
that systemic effects like cytokine and hormone levels were
more essential than insulitis grade for the overall diabetes
development in these mice.
In conclusion, BPA, but not phthalate exposure, increase
the diabetes development in NOD mice, probably due to
reduced macrophage number and function. The combina-
tion of BPA and phthalates resulted in systemic alterations
in cytokine secretion from immune cells, but did not affect
the overall diabetes development. The apparent coun-
teracting effect of phthalates on the BPA-induced T1D
development could be due to non-monotonic effects of
endocrine disruptors in the NOD mouse model, where
high doses of EDs may  decrease the diabetes development,
and/or altered cytokine levels affecting inﬂammation or
beta-cell survival and insulin secretion. There are so
far no epidemiological studies investigating associations
between T1DM development and exposure to BPA and/or
phthalates. Such studies are necessary to document the
human relevance of these environmental chemicals as trig-
gers for development of T1DM.
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